{"id":2394,"date":"2019-02-28T00:00:00","date_gmt":"2019-02-28T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2394"},"modified":"2019-02-28T00:00:00","modified_gmt":"2019-02-28T00:00:00","slug":"centogene-anuncia-una-colaboracion-estrategica-con-sarepta-therapy","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/es\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/","title":{"rendered":"CENTOGENE anuncia colaboraci\u00f3n estrat\u00e9gica con Sarepta Therapeutics"},"content":{"rendered":"

CENTOGENE anunci\u00f3 hoy una colaboraci\u00f3n estrat\u00e9gica de 12 meses con Sarepta Therapeutics, Inc.<\/a> (NASDAQ:SRPT) para la identificaci\u00f3n de pacientes con distrofia muscular de Duchenne (DMD) en la regi\u00f3n de Medio Oriente y el norte de \u00c1frica.<\/p>\n

CENTOGENE realizar\u00e1 pruebas de diagn\u00f3stico molecular completas mediante an\u00e1lisis de deleci\u00f3n\/duplicaci\u00f3n y secuenciaci\u00f3n completa del gen DMD en pacientes negativos a MLPA. Seg\u00fan los t\u00e9rminos del acuerdo con Sarepta, CENTOGENE tambi\u00e9n prestar\u00e1 servicios de diagn\u00f3stico a los m\u00e9dicos que traten a pacientes con s\u00edntomas relacionados con la DMD. Los m\u00e9dicos pueden enviar una muestra del paciente mediante CentoCard\u00ae, el kit patentado y validado de recolecci\u00f3n de sangre seca de CENTOGENE, utilizando una peque\u00f1a cantidad de sangre.<\/p>\n

\u201cNuestra colaboraci\u00f3n con Sarepta Therapeutics demuestra a\u00fan m\u00e1s el compromiso de CENTOGENE con la aceleraci\u00f3n del desarrollo de nuevos medicamentos hu\u00e9rfanos, aprovechando nuestro conocimiento del mercado global de enfermedades raras, en particular nuestra experiencia en la identificaci\u00f3n de pacientes con DMD\u201d, coment\u00f3 el Dr. Arndt Rolfs, director ejecutivo y fundador de CENTOGENE. \u201cHoy, mientras el mundo conmemora el D\u00eda de las Enfermedades Raras y los enormes desaf\u00edos que enfrentan a diario las personas que viven con una enfermedad rara, seguimos comprometidos con la transformaci\u00f3n de la ciencia de la informaci\u00f3n gen\u00e9tica en soluciones y con la esperanza de que los pacientes con enfermedades raras y sus familias se beneficien\u201d.\u201d<\/p>\n

\u201cEl objetivo de Sarepta es brindar una vida mejor a todas las personas con DMD elegibles en todo el mundo, y hacerlo con la mayor rapidez posible. El acuerdo de hoy con CENTOGENE es un paso m\u00e1s para lograr este objetivo\u201d, declar\u00f3 Doug Ingram, presidente y director ejecutivo de Sarepta.<\/p>\n

La DMD es un trastorno gen\u00e9tico que afecta aproximadamente a 1 de cada 3500 a 5000 ni\u00f1os reci\u00e9n nacidos. Este trastorno causa debilidad progresiva y atrofia muscular, y se debe a la falta de distrofina, una prote\u00edna esencial que ayuda a mantener intactas las c\u00e9lulas musculares. La debilidad muscular se hace cada vez m\u00e1s evidente entre los 3 y los 5 a\u00f1os de edad, y la mayor\u00eda de los pacientes utilizan silla de ruedas a los 13 a\u00f1os, tras haber perdido la capacidad de caminar. Durante la adolescencia, el deterioro de los m\u00fasculos card\u00edacos y respiratorios provoca complicaciones graves y potencialmente mortales.<\/p>","protected":false},"excerpt":{"rendered":"

CENTOGENE anunci\u00f3 hoy una colaboraci\u00f3n estrat\u00e9gica de 12 meses con Sarepta Therapeutics, Inc. para la identificaci\u00f3n de pacientes con distrofia muscular de Duchenne (DMD) en la regi\u00f3n de Medio Oriente y el norte de \u00c1frica.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2394","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nCENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/es\/centogene-anuncia-una-colaboracion-estrategica-con-sarepta-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"CENTOGENE today announced a 12-month strategic collaboration with Sarepta Therapeutics, Inc. for the identification of patients with Duchenne muscular dystrophy (DMD) in the Middle East and North Africa region.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/es\/centogene-anuncia-una-colaboracion-estrategica-con-sarepta-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2019-02-28T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics\",\"datePublished\":\"2019-02-28T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/\"},\"wordCount\":327,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/\",\"name\":\"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2019-02-28T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/es\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE anuncia una colaboraci\u00f3n estrat\u00e9gica con Sarepta Therapeutics | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/es\/centogene-anuncia-una-colaboracion-estrategica-con-sarepta-therapy\/","og_locale":"es_ES","og_type":"article","og_title":"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics | CENTOGENE","og_description":"CENTOGENE today announced a 12-month strategic collaboration with Sarepta Therapeutics, Inc. for the identification of patients with Duchenne muscular dystrophy (DMD) in the Middle East and North Africa region.","og_url":"https:\/\/www.centogene.com\/es\/centogene-anuncia-una-colaboracion-estrategica-con-sarepta-therapy\/","og_site_name":"CENTOGENE","article_published_time":"2019-02-28T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admincg","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics","datePublished":"2019-02-28T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/"},"wordCount":327,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/","url":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/","name":"CENTOGENE anuncia una colaboraci\u00f3n estrat\u00e9gica con Sarepta Therapeutics | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2019-02-28T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-announces-strategic-collaboration-with-sarepta-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE Announces Strategic Collaboration with Sarepta Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Impulsar la medicina de precisi\u00f3n","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"administrador","url":"https:\/\/www.centogene.com\/es\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/comments?post=2394"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2394\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/media?parent=2394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/categories?post=2394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/tags?post=2394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}